Eli Lilly's much-anticipated drug for diabetes and obesity, that competes with Ozempic globally, is now in India-here's what ...

Mumbai-based Kilitch Drugs Ltd plans to enter biosimilars and oral solids, including diabetic and weight-loss tablets, and is ...

With the expiration of Boehringer Ingelheim’s patent on Empagliflozin, several Indian pharmaceutical companies are set to ...

Spooked by US president's threat, several Indian pharma players lobby for blanket duty waiver on drugs coming from America, ...

The Nifty Pharma index closed on a positive note on Tuesday. Shares of J B Chemicals & Pharmaceuticals Ltd.(up 4.48 per cent) ...

Stock market recommendations: Bajaj Broking Research recommends Piramal Pharma and PTC India for the upcoming week. Nifty is expected to remain volatile, with key support at 22,000-21,700 levels.

Indian Pharmaceuticals Market has delivered marginally lower revenue at 7.5% year on year in February 2025, compared to 8.7% ...

Indian pharma companies are expanding in the US through acquisitions to navigate regulations, diversify portfolios, and ...

Marksans Pharma shares rose over 4% after its Goa plant secured Australian TGA approval for solid dosage forms. Its UK arm ...

Novo and Lilly’s campaigns are not limited to advertisements alone, and both companies are trying to raise awareness around obesity through research studies and conferences.